Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 26, No. 3, 2005   

Free Abstract     Article (References)     Article (PDF 642 KB)     

Research Article

A New Experimental Rat Model of Osteosarcoma Established by Intrafemoral Tumor Cell Inoculation, Useful for Biology and Therapy Investigations
B. Cherriera, F. Gouina, M.-F. Heymannb, J.P. Thiéryc, F. Rédinia, D. Heymanna, F. Duteillea

aPhysiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Faculté de Médecine, Université de Nantes EA 3822, INSERM ERI 7, Nantes,
bDépartement de Pathologie, Hôpital Nord Laennec, St Herblain, et
cHôpital Paul Brousse, Villejuif, France

Address of Corresponding Author

Tumor Biol 2005;26:121-130 (DOI: 10.1159/000086483)


 goto top of page Key Words

  • Osteosarcoma
  • Lung metastasis

 goto top of page Abstract

Satisfactory experimental models for preclinical cancer studies must follow several criteria: (1) reproducibility of the method used to induce the tumor and (2) clinical, pathological and kinetic similarity with the corresponding human tumors. We developed a model of osteosarcoma locally induced by the intrafemoral injection of osteosarcoma (OSR) cells in Sprague-Dawley rats. This method yields nearly 80% of bone tumors at the injection site. These tumors double their volume fairly slowly (in approximately 20 days) and lung metastases occur in 96% of the animals. The OSR cell-induced tumor is characterized by a direct production of mineralized matrix by the tumor cells themselves, as revealed by histochemical analysis. The microarchitectural parameters which were quantified by a microscanner show an increased trabecular bone volume (+238%) when OSR cells were injected in the femur, as compared to controls injected with vehicle. Osteoblastic markers such as alkaline phosphatase, osteopontin, osteocalcin and bone sialoprotein were expressed by the tumor in vivo, whereas the initially injected OSR cells did not express some of these markers, suggesting that OSR cells reacquired an osteoblastic phenotype in a favorable environment. The clinical, radiological and histological data show that this model shares high similarities with the osteocondensing forms of osteosarcoma in humans.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Dr. Françoise Redini
Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives
Faculté de Médecine, Université de Nantes EA 3822, INSERM ERI 7, 1 rue Gaston Veil
FR-44035 Nantes Cedex 1 (France)
Tel. +33 240 412 845, Fax +33 240 412 860, E-Mail francoise.redini@sante.univ-nantes.fr


 goto top of page Article Information

Received: September 28, 2004
Accepted after revision: December 4, 2004
Published online: June 17, 2005
Number of Print Pages : 10
Number of Figures : 7, Number of Tables : 3, Number of References : 29

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15970646)
Download Citation




copyright  © 2008 S. Karger AG, Basel